$IKT News : Inhibikase Therapeutics to Present at
Post# of 15352
![Avatar](/images/ProfileImages/982093748_22164_no_avatar_available.jpg)
ATLANTA, May 25, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced that Dr. Milton Werner, Ph.D., Chief Executive Officer of Inhibikase, will present at the Jefferies Virtual Healthcare Conference:
https://finance.yahoo.com/news/inhibikase-the...00040.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)